Alkermes plc.
$7.66B- Market cap
- $7.73B
- Debt
- +$317.13M
- Cash
- −$388.57M
Capital structure 96% equity / 4% debt · EV / Revenue 5.19x · EV / EBITDA 23.76x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $7.73B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: ALKS stock price near parity vs CART $46.10 current versus $45.64 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CART's multiple
Implied fair value · at ALKS's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple premium
Expensive
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ALKS FY 2025 (ended Dec 31, 2025) · CART FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 96% equity / 4% debt · EV / Revenue 5.19x · EV / EBITDA 23.76x
Capital structure 94% equity / 6% debt · EV / Revenue 3.16x · EV / EBITDA 20.98x
CART carries the larger enterprise value at $11.83B against $7.66B; CART trades on the lower EV / Revenue multiple (3.16x vs 5.19x); CART on the lower EV / EBITDA (20.98x vs 23.76x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Alkermes plc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
MAPLEBEAR INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.17x
0.28x
Net debt / EBITDA
Leverage against operating earnings
-0.22x
0.02x
Cash and equivalents
Liquid reserves on the balance sheet
$388.57M
$687.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Jazz Pharmaceuticals plc
ALKS vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
ALKS vs SUPN
Amneal Pharmaceuticals, Inc.
ALKS vs AMRX
DoorDash, Inc.
ALKS vs DASH
Uber Technologies, Inc
ALKS vs UBER
Lyft, Inc.
ALKS vs LYFT
TaskUs, Inc.
ALKS vs TASK
Genpact LTD
ALKS vs G
Concentrix Corp
ALKS vs CNXC
$317.13M
$699.00M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.